CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 95 filers reported holding CTI BIOPHARMA CORP in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $82,000 | +20.6% | 200 | 0.0% | 0.00% | – |
Q2 2016 | $68,000 | -35.8% | 200 | 0.0% | 0.00% | – |
Q1 2016 | $106,000 | -56.9% | 200 | 0.0% | 0.00% | – |
Q4 2015 | $246,000 | -49.2% | 200 | 0.0% | 0.00% | – |
Q3 2015 | $484,000 | -59.3% | 200 | -52.7% | 0.00% | – |
Q2 2015 | $1,189,000 | +228.5% | 423 | +111.5% | 0.00% | – |
Q1 2015 | $362,000 | -25.2% | 200 | 0.0% | 0.00% | – |
Q3 2014 | $484,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST NEW YORK SECURITIES LLC /NY | 191,000 | $345,710,000 | 0.34% |
TFS CAPITAL LLC | 1,182,304 | $2,140,000 | 0.21% |
TURNER INVESTMENTS LLC | 530,100 | $959,000 | 0.17% |
DRW Securities, LLC | 486,953 | $881,000 | 0.14% |
Candriam S.C.A. | 1,445,000 | $2,616,000 | 0.05% |
First Heartland Consultants, Inc. | 74,624 | $135,000 | 0.05% |
WASHINGTON TRUST Co | 410,616 | $743,000 | 0.05% |
EAGLE ASSET MANAGEMENT INC | 4,332,630 | $7,842,000 | 0.04% |
JW Asset Management, LLC | 52,271 | $95,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 702,571 | $1,272,000 | 0.03% |